Nanoparticle-Enabled Enrichment of Longitudinal Blood Proteomic Fingerprints in Alzheimer’s Disease

[Image: see text] Blood-circulating biomarkers have the potential to detect Alzheimer’s disease (AD) pathology before clinical symptoms emerge and to improve the outcomes of clinical trials for disease-modifying therapies. Despite recent advances in understanding concomitant systemic abnormalities,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hadjidemetriou, Marilena, Rivers-Auty, Jack, Papafilippou, Lana, Eales, James, Kellett, Katherine A. B., Hooper, Nigel M., Lawrence, Catherine B., Kostarelos, Kostas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155389/
https://www.ncbi.nlm.nih.gov/pubmed/33730479
http://dx.doi.org/10.1021/acsnano.1c00658

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155389/
https://www.ncbi.nlm.nih.gov/pubmed/33730479
http://dx.doi.org/10.1021/acsnano.1c00658

Ejemplares similares